E-resources
Peer reviewed
-
Riihijärvi, Sari; Taskinen, Minna; Jerkeman, Mats; Leppä, Sirpa
European journal of haematology, February 2011, Volume: 86, Issue: 2Journal Article
Male gender is an adverse prognostic factor in Hodgkin’s lymphoma, but no such association has yet been established in non‐Hodgkin lymphomas. Here, we have evaluated whether gender has prognostic impact on the survival of patients with B‐cell non‐Hodgkin lymphoma in the postrituximab era of lymphoma therapies. The study populations consisted of 217 diffuse large B‐cell lymphoma (DLBCL) and 110 follicular lymphoma (FL) patients treated with immunochemotherapy. Hundred and sixty chemotherapy‐treated DLBCL patients served as a control group. According to Kaplan–Meier analyses, female patients had a significantly better progression‐free survival than men both in DLBCL (4 yr PFS 75% vs. 60%; P = 0.013) and in FL (4 yr PFS 68% vs. 52%, P = 0.036) patients treated with immunochemotherapy. In chemotherapy‐treated DLBCL patients, no difference in survival between the genders was found. The results support the idea that women seem to respond better to rituximab.
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.